Reboxetine, a selective norepinephrine reuptake inhibitor normally prescribed for depression, can reduce sleep apnea symptom severity.
Reboxetine, a selective norepinephrine reuptake inhibitor normally prescribed for depression, can reduce sleep apnea symptom severity.